General Endocrinology

Latest News

Once-Weekly Treatment for Adult GH Deficiency Effective in Phase 3 Trial

By

Rose Reeb

A once-weekly growth hormone replacement therapy demonstrated superiority over placebo for patients with adult growth hormone deficiency.

Point-of-Care MRI System Granted FDA Clearance

By

Steve Duffy

The FDA has granted 510(k) clearance to the Hyperfine system (Hyperfine Research), a bedside magnetic resonance imaging (MRI) system.

Screening for Depression in Perimenopausal Women Often Neglected

By

Madeline Morr

Researchers sought to better understand the clinical practice patterns of ob-gyn physicians regarding their screening practices and management of depression during menopause.

AI and Machine Learning Technology Can Detect Nocturnal Hypoglycemic Events

By

Brandon May

Researchers have developed an artificial intelligence (AI)-driven, noninvasive technology that is capable of detecting nocturnal hypoglycemic events from raw ECG signals without the need for a finger-prick test.

Arterial Stiffness May Increase Within Year of Final Menstrual Period

Changes in arterial stiffness are greater within one year of a woman’s final menstrual period.

Lifestyle Intervention via Smartphone App Effective for Pregnant Women With Obesity

By

Amit Akirov, MD

A continuous behavioral lifestyle intervention supported by a smartphone app can assist in improving dietary intake and physical activity among pregnant women with overweight and obesity.

Medical Group Opposes States’ Limits on Access to Gender-Affirming Treatment for Transgender Youth

A group of medical professionals in southern states opposes proposals that would limit transgender minors’ access to gender-affirming health care such as hormone therapy and surgery.

Nutrition, Stress, Environment and Their Association With Acne

By

Morgan E. Meissner

Nutrition, pollution, stress, and harsh skin care — climate and sun exposure, too — may be the most frequent contributing factors to acne, according to a large, international study.

New Pancrelipase Formulation Approved With Extended Shelf Life

By

Steve Duffy

The Food and Drug Administration has approved a new formulation of Pancreaze (pancrelipase; Vivus) Delayed Release Capsules which would allow for an extended shelf life of 36 months.

More Research Is Needed to Better Diagnose, Treat Systemic Chronic Inflammation

By

Brandon May

In an effort to prevent and lower the risk of inflammation-related diseases, a multi-institutional team of researchers based in the United States, South America, and Europe are calling for improvements to the way in which systemic chronic inflammation is diagnosed and treated.

Women With Anorexia Nervosa at High Risk for Bone Fractures

By

Laurel Ranger

A study found that patients with anorexia nervosa have a particularly high risk for hip, vertebral, and upper arm fractures.